Now showing items 1-3 of 3

    • Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy 

      Reddy, Sushma; Fung, Alan; Manlhiot, Cedric; Selamet Tierney, Elif Seda; Chung, Wendy K.; Blume, Elizabeth; Kaufman, Beth D.; Goldmuntz, Elizabeth; Colan, Steven; Mital, Seema (Nature Publishing Group, 2015)
      Background: Adrenergic receptor (ADR) genotypes are associated with heart failure (HF) and β-blocker response in adults. We assessed the influence of ADR genotypes in children with dilated cardiomyopathy (DCM). Methods: ...
    • Longitudinal Assessment of Growth in Hypoplastic Left Heart Syndrome: Results From the Single Ventricle Reconstruction Trial 

      Burch, Phillip T.; Gerstenberger, Eric; Ravishankar, Chitra; Hehir, David A.; Davies, Ryan R.; Colan, Steven D.; Sleeper, Lynn A.; Newburger, Jane W.; Clabby, Martha L.; Williams, Ismee A.; Li, Jennifer S.; Uzark, Karen; Cooper, David S.; Lambert, Linda M.; Pemberton, Victoria L.; Pike, Nancy A.; Anderson, Jeffrey B.; Dunbar‐Masterson, Carolyn; Khaikin, Svetlana; Zyblewski, Sinai C.; Minich, L. LuAnn (Blackwell Publishing Ltd, 2014)
      Background: We sought to characterize growth between birth and age 3 years in infants with hypoplastic left heart syndrome who underwent the Norwood procedure. Methods and Results: We performed a secondary analysis using ...
    • Report on the International Colloquium on Cardio-Oncology (Rome, 12–14 March 2014) 

      Ewer, Michael; Gianni, Luca; Pane, Fabrizio; Sandri, Maria Teresa; Steiner, Rudolf K; Wojnowski, Leszek; Yeh, Edward T; Carver, Joseph R; Lipshultz, Steven E; Minotti, Giorgio; Armstrong, Gregory T; Cardinale, Daniela; Colan, Steven D; Darby, Sarah C; Force, Thomas L; Kremer, Leontien CM; Lenihan, Daniel J; Sallan, Stephen E; Sawyer, Douglas B; Suter, Thomas M; Swain, Sandra M; van Leeuwen, Flora E (Cancer Intelligence, 2014)
      Cardio-oncology is a relatively new discipline that focuses on the cardiovascular sequelae of anti-tumour drugs. As any other young adolescent discipline, cardio-oncology struggles to define its scientific boundaries and ...